MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 59 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 76 | +100.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 38 | -100.0% | 0.00% | – |
| Q1 2023 | $134 | +7.2% | 190,007 | +14.0% | 0.00% | – |
| Q4 2022 | $125 | -99.6% | 166,641 | +322.2% | 0.00% | – |
| Q3 2022 | $34,000 | +54.5% | 39,470 | +97.4% | 0.00% | – |
| Q2 2022 | $22,000 | -95.4% | 20,000 | -95.3% | 0.00% | – |
| Q1 2022 | $477,000 | -60.0% | 426,085 | -42.9% | 0.00% | – |
| Q4 2021 | $1,192,000 | +2383.3% | 745,588 | +3627.9% | 0.00% | – |
| Q3 2021 | $48,000 | -23.8% | 20,000 | 0.0% | 0.00% | – |
| Q2 2021 | $63,000 | -76.3% | 20,000 | -74.7% | 0.00% | – |
| Q1 2021 | $266,000 | – | 78,988 | +987250.0% | 0.00% | – |
| Q2 2019 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |